AsOf

A day on the record

On , 2 claims took effect on the record: 1 money & deals, 1 other. 46,379 claims were recorded or updated that day.

The Brief Three things that changed on the weekend of and

Became true

2

Stopped being true

0

None.

Recorded or changed on this day

first 50 of 46,379
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,740,600,687 shares
Abbott Laboratories shares outstanding: 1,740,600,687 shares, claim clm_00A19041C7EC · ended · superseded by clm_749951A1C0C9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 6,709,000,000 United States dollar
Abbott Laboratories cash and equivalents: 6,709,000,000 United States dollar, claim clm_01C8A8BA9FB2 · ended · superseded by clm_658B87946AB9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 42,903,346,000 United States dollar
Abbott Laboratories total assets: 42,903,346,000 United States dollar, claim clm_01D207199632 · ended · superseded by clm_498E70E89BD2 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,508,977,828 shares
Abbott Laboratories shares outstanding: 1,508,977,828 shares, claim clm_01EFFCB41E1C · ended · superseded by clm_B73D3A7A5FA7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 1,318,000,000 United States dollar
Abbott Laboratories quarterly net income: 1,318,000,000 United States dollar, claim clm_021A4A96F575 · ended · superseded by clm_53901BDE4225 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,735,357,980 shares
Abbott Laboratories shares outstanding: 1,735,357,980 shares, claim clm_027756C1CA20 · ended · superseded by clm_DDC41F7C4050 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 1,989,053,000 United States dollar
Abbott Laboratories quarterly operating income: 1,989,053,000 United States dollar, claim clm_03034FC0B962 · ended · superseded by clm_C62521896403 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,546,185,646 shares
Abbott Laboratories shares outstanding: 1,546,185,646 shares, claim clm_03EB3A67DDC7 · ended · superseded by clm_F3B60AD32165 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,547,581,805 shares
Abbott Laboratories shares outstanding: 1,547,581,805 shares, claim clm_0410A6F2C43D · ended · superseded by clm_0C2AEF8174B5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,505,790,586 shares
Abbott Laboratories shares outstanding: 1,505,790,586 shares, claim clm_046691A1A0C0 · ended · superseded by clm_01EFFCB41E1C · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
Abbott Laboratories · research and development · 2,942,000,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · research and development · 2,300,000,000 United States dollar
Abbott Laboratories research and development: 2,300,000,000 United States dollar, claim clm_0556A1975396 · ended · superseded by clm_E3A1981FFAA1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 5,369,138,000 United States dollar
Abbott Laboratories quarterly revenue: 5,369,138,000 United States dollar, claim clm_05BD8CC8CEE0 · ended · superseded by clm_B233A6055639 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 316,000,000 United States dollar
Abbott Laboratories quarterly net income: 316,000,000 United States dollar, claim clm_0603855B1B45 · ended · superseded by clm_D6BBD632FF41 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 2,456,384,000 United States dollar
Abbott Laboratories cash and equivalents: 2,456,384,000 United States dollar, claim clm_06133819F221 · ended · superseded by clm_9FCEFBC20CAB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 1,077,000,000 United States dollar
Abbott Laboratories quarterly net income: 1,077,000,000 United States dollar, claim clm_0713CDEDD078 · ended · superseded by clm_260A61887540 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
Abbott Laboratories · quarterly revenue · 13,013,000,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 39,713,924,000 United States dollar
Abbott Laboratories total assets: 39,713,924,000 United States dollar, claim clm_08CB81E0BF16 · ended · superseded by clm_90CA3B235E37 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 20,675,000,000 United States dollar
Abbott Laboratories total equity: 20,675,000,000 United States dollar, claim clm_08EC8818E782 · ended · superseded by clm_F5A188432375 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,772,817,349 shares
Abbott Laboratories shares outstanding: 1,772,817,349 shares, claim clm_08F7D872BEBD · ended · superseded by clm_FC36D396E40F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 24,439,833,000 United States dollar
Abbott Laboratories total equity: 24,439,833,000 United States dollar, claim clm_09169A44136C · ended · superseded by clm_6B7C46E76D25 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 537,000,000 United States dollar
Abbott Laboratories quarterly net income: 537,000,000 United States dollar, claim clm_095EBCF0260A · ended · superseded by clm_146580C19233 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 57,373,620,000 United States dollar
Abbott Laboratories total assets: 57,373,620,000 United States dollar, claim clm_0A2F6FD9A825 · ended · superseded by clm_273981693F13 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 7,726,000,000 United States dollar
Abbott Laboratories quarterly revenue: 7,726,000,000 United States dollar, claim clm_0C0541A5EB25 · ended · superseded by clm_9EA536FA1B5B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,554,282,988 shares
Abbott Laboratories shares outstanding: 1,554,282,988 shares, claim clm_0C2AEF8174B5 · ended · superseded by clm_8274522F4DD8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · revenue · 20,247,000,000 United States dollar
Abbott Laboratories revenue: 20,247,000,000 United States dollar, claim clm_0D3539091ADB · ended · superseded by clm_16E555E53E25 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 1,605,966,000 United States dollar
Abbott Laboratories quarterly operating income: 1,605,966,000 United States dollar, claim clm_0D38DCBAC1D9 · ended · superseded by clm_5422E43B6140 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
Abbott Laboratories · quarterly net income · 920,000,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · net income · 477,000,000 United States dollar
Abbott Laboratories net income: 477,000,000 United States dollar, claim clm_0E0A2ADD6C11 · ended · superseded by clm_431C6CD455C6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 33,800,000,000 United States dollar
Abbott Laboratories total equity: 33,800,000,000 United States dollar, claim clm_0E0ED6C2D2F1 · ended · superseded by clm_F790E66651DD · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 713,000,000 United States dollar
Abbott Laboratories quarterly operating income: 713,000,000 United States dollar, claim clm_0E1A644D6289 · ended · superseded by clm_386CF61547F5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,741,812,429 shares
Abbott Laboratories shares outstanding: 1,741,812,429 shares, claim clm_0EA7146A2063 · ended · superseded by clm_AC459049B414 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,737,443,264 shares
Abbott Laboratories shares outstanding: 1,737,443,264 shares, claim clm_0F510C806C66 · ended · superseded by clm_00A19041C7EC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 63,257,738,000 United States dollar
Abbott Laboratories total assets: 63,257,738,000 United States dollar, claim clm_0F6ED49CB4F4 · ended · superseded by clm_B8A0C7E5A98B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,738,871,947 shares
Abbott Laboratories shares outstanding: 1,738,871,947 shares, claim clm_0F8EC0C78816 · ended · superseded by clm_98DC25486509 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 630,339,000 United States dollar
Abbott Laboratories quarterly operating income: 630,339,000 United States dollar, claim clm_102398756A32 · ended · superseded by clm_1937F4CF953B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 81,414,000,000 United States dollar
Abbott Laboratories total assets: 81,414,000,000 United States dollar, claim clm_114AF086ADE9 · ended · superseded by clm_27D6994F8B52 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 3,475,000,000 United States dollar
Abbott Laboratories cash and equivalents: 3,475,000,000 United States dollar, claim clm_11779D774E56 · ended · superseded by clm_DBA8DBEBFC34 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 47,664,000,000 United States dollar
Abbott Laboratories total equity: 47,664,000,000 United States dollar, claim clm_117E87574745 · ended · superseded by clm_263DBDF600A7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 1,325,000,000 United States dollar
Abbott Laboratories quarterly net income: 1,325,000,000 United States dollar, claim clm_1188A2534E22 · ended · superseded by clm_E37C754C8FCC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · net income · 6,933,000,000 United States dollar
Abbott Laboratories net income: 6,933,000,000 United States dollar, claim clm_11981DF05BC7 · ended · superseded by clm_1E79DAD01E1C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 50,565,000,000 United States dollar
Abbott Laboratories total equity: 50,565,000,000 United States dollar, claim clm_11FDBB86160D · ended · superseded by clm_D5EE83B1870A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 31,088,000,000 United States dollar
Abbott Laboratories total equity: 31,088,000,000 United States dollar, claim clm_1226C199906C · ended · superseded by clm_178BA35B231F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly research and development · 766,000,000 United States dollar
Abbott Laboratories quarterly research and development: 766,000,000 United States dollar, claim clm_1266BBB313EF · ended · superseded by clm_F408F42211E9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 72,248,000,000 United States dollar
Abbott Laboratories total assets: 72,248,000,000 United States dollar, claim clm_129A9E1E6676 · ended · superseded by clm_60A75BEF73AA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 10,635,000,000 United States dollar
Abbott Laboratories quarterly revenue: 10,635,000,000 United States dollar, claim clm_12D7EF8B99CE · ended · superseded by clm_B19E42064034 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 731,000,000 United States dollar
Abbott Laboratories quarterly operating income: 731,000,000 United States dollar, claim clm_1340152CB9B1 · ended · superseded by clm_93E168E8343C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · revenue · 31,904,000,000 United States dollar
Abbott Laboratories revenue: 31,904,000,000 United States dollar, claim clm_1395DECF0604 · ended · superseded by clm_C6D9CE4452DC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 67,887,000,000 United States dollar
Abbott Laboratories total assets: 67,887,000,000 United States dollar, claim clm_13B501924E09 · ended · superseded by clm_A0B8EEF54F83 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 1,232,000,000 United States dollar
Abbott Laboratories quarterly net income: 1,232,000,000 United States dollar, claim clm_146580C19233 · ended · superseded by clm_9F497245599A · 1 source (1 primary) · conf 0.95

All 46,379, 50 a page →

What the statuses mean